will hims stop selling semaglutide & Hers stock falls 25% as FDA curtails compounded GLP-1s Hims does not sell Tirzepatide.

Mission: democratize skincare knowledge so our community makes savvy choices.

Wenthur, a research associate in the Janda laboratory

Since then, Wegovy has gained additional approvals for use in pediatric patients aged 12 and older with obesity and to reduce the risk of MACE in adults with established cardiovascular disease who are overweight or obese

Explore detailed drug insights and clinical data at www.clival.com #GLP1 #DiabetesCare #ObesityTreatment #PharmaInsights #DrugDatabase #ClivalDatabase To view or add a comment, sign in Indias drug regulator has officially approved Ozempic (semaglutide injection) by Novo Nordisk for the treatment of Type 2 Diabetes

A post-hoc propensity-matched cohort from the EXSCEL trial with the GLP-1RA exenatide demonstrated that the addition of exenatide in patients on a background of SGLT2 inhibition tended to exhibit improvements in MACE and all-cause mortality, and slower rates of renal decline compared to patients not on an SGLT2 inhibitor 77

doi:10.4103/ijem.ijem_423_21